US › Healthcare

Alamar Biosciences, Inc. Common Stock (ALMR)

US · Healthcare · Medical Devices

$27.11+0.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$26.0M
Net profit
$-21.3M
EPS
$-1.74
Net margin
-81.9%

Key statistics

Market cap
$1.88B
Forward P/E
0.0
P/B
0.00
Book value
$-2.57
EPS (TTM)
$-0.65
52-week high
$29.43
52-week low
$17.00
50-day MA
$23.51
200-day MA
$23.54

Analyst view

with an average price target of $31.80.

Shareholding

Insiders
26.67%
Institutions
36.02%

Largest institutional holders

FundStake
Davy Asset Management Limited0.05%
Dymon Asia Capital (Singapore) Pte. Ltd0.02%
North Star Investment Management Corp0.00%

Recent filings & reports

DocumentDate
Company announcement · Q3 20262026-07-15
Quarterly report · Q1 20262026-05-08
Results announced · Q2 20262026-05-08
Charter / bylaws change · Q2 20262026-04-20

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alamar Biosciences, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.